Oncolytics Biotech Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-19.9M | $-20.1M | $174.0K | $2.0M |
| FY2025 | $-20.1M | $-20.1M | $6.0K | $3.1M |
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2024 | $-19.9M | $-20.1M | $174.0K | $2.0M |
| FY2025 | $-20.1M | $-20.1M | $6.0K | $3.1M |